PT  - JOURNAL ARTICLE
AU  - Frans Dekker
AU  - Arie Knuistingh Neven
AU  - Boukje Andriesse
AU  - David Kernick
AU  - Michel D Ferrari
AU  - Willem JJ Assendelft
TI  - Prophylactic treatment of migraine by GPs: a qualitative study
AID  - 10.3399/bjgp12X636100
DP  - 2012 Apr 01
TA  - British Journal of General Practice
PG  - e268--e274
VI  - 62
IP  - 597
4099  - http://bjgp.org/content/62/597/e268.short
4100  - http://bjgp.org/content/62/597/e268.full
SO  - Br J Gen Pract2012 Apr 01; 62
AB  - Background Despite the considerable impact of migraine, the use of preventive medication in primary care is limited. Only about 5% of migraine patients who qualify for prophylaxis actually receive it, and adherence is far from optimal.Aim To explore the opinions of GPs regarding preventive medication for migraine.Design and setting A qualitative focus group study in Dutch general practice.Method Four focus groups (six GPs each) were formed. GPs were purposively sampled to acquire a range of participants, reflecting the more general GP population.Results GPs perceived patients' concerns about the impact of migraine and the potential benefits of prophylaxis. However, some were hesitant to start prescribing prophylaxis due to doubts about effectiveness, potential side effects, and the risk of developing drug dependency. GPs' decisions were often based on considerations other than those presented in national guidelines, for example, the patient's need to control their own problem. Many GPs placed responsibility for initiating prophylaxis with the patient.Conclusion Various considerations hamper GPs from managing migraine with preventive medication, and various patient-related concerns cause GPs to deviate from national headache guidelines.